(Q85922325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Renal-cell carcinoma: a step closer to a new classification (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

Toni K Choueiri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3

Sabina Signoretti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Mark M Pomerantz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

16 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

105-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

Hereditary kidney cancer: unique opportunity for disease-based therapy.

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

BAP1 loss defines a new class of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970599-5

7 January 2021

10.1016/S1470-2045(12)70599-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23333115%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference